[Unusual speech dominance in a stroke patient].
Jensen
U
U
Pötter-Nerger
M
M
Ulmer
S
S
D000368:Aged; D001013:Aorta, Thoracic / Q000473:pathology / Q000601:surgery; D001039:Aphasia, Broca / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D001041:Aphasia, Wernicke / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D017536:Carotid Artery, Common / Q000473:pathology / Q000601:surgery; D002540:Cerebral Cortex / Q000098:blood supply; D002544:Cerebral Infarction / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D002548:Cerebral Revascularization; D038524:Diffusion Magnetic Resonance Imaging; D004292:Dominance, Cerebral / Q000502:physiology*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D021621:Imaging, Three-Dimensional; D018810:Magnetic Resonance Angiography; D008279:Magnetic Resonance Imaging; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis; D013060:Speech / Q000502:physiology*; D013348:Subclavian Artery / Q000473:pathology / Q000601:surgery; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D018616:Ultrasonography, Doppler, Duplex; D014715:Vertebrobasilar Insufficiency / Q000175:diagnosis / Q000601:surgery
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator